{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:42:56Z","timestamp":1789875776879,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00192-012-2009-3","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T15:34:16Z","timestamp":1355153656000},"page":"537-543","source":"Crossref","is-referenced-by-count":99,"title":["The vagina as a route for drug delivery: a review"],"prefix":"10.1007","volume":"24","author":[{"given":"Sushma","family":"Srikrishna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"2009_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/oxfordjournals.humrep.a137666","volume":"7","author":"P Acien","year":"1992","unstructured":"Acien P (1992) Embryological observations on the female genital tract. Hum Reprod 7:437\u2013445","journal-title":"Hum Reprod"},{"key":"2009_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0950-351X(98)80427-8","volume":"12","author":"R Rey","year":"1998","unstructured":"Rey R, Picard JY (1998) Embryology and endocrinology of genital development. Bailliere Clin Endocrinol Metab 12:17\u201333","journal-title":"Bailliere Clin Endocrinol Metab"},{"key":"2009_CR3","first-page":"123","volume":"13","author":"R O\u2019Rahilly","year":"1977","unstructured":"O\u2019Rahilly R (1977) The development of the vagina in the human. Birth Defects Orig Artic Ser 13:123\u2013136","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2009_CR4","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/00007611-197812000-00026","volume":"71","author":"MI Funt","year":"1978","unstructured":"Funt MI, Thompson JD, Birch H (1978) Normal vaginal axis. South Med J 71:1534\u20131535","journal-title":"South Med J"},{"key":"2009_CR5","first-page":"39","volume-title":"Human reproductive medicine: The human vagina","author":"W Platzner","year":"1978","unstructured":"Platzner W, Poisel S, Hafez ESE (1978) Functional anatomy of the human vagina. In: Hafez ESE, Evans TN (eds) Human reproductive medicine: The human vagina. North Holland Publishing, New York, pp 39\u201354"},{"key":"2009_CR6","volume-title":"Comprehensive gynecology","author":"AL Herbst","year":"1992","unstructured":"Herbst AL, Mishell DR, Stenchever MA, Droegemueller W (1992) Comprehensive gynecology, 2nd edn. Mosby Year Book, St. Louis","edition":"2"},{"key":"2009_CR7","volume-title":"TeLinde\u2019s operative gynecology","author":"JA Rock","year":"1977","unstructured":"Rock JA, Thompson JD (1977) TeLinde\u2019s operative gynecology, 8th edn. Lippincott-Raven, Philadelphia","edition":"8"},{"key":"2009_CR8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","volume":"828","author":"D Ziegler De","year":"1997","unstructured":"De Ziegler D, Bulletti C, De Monstier B, Jaaskelainen AS (1997) The first uterine pass effect. Ann N Y Acad Sci 828:291\u2013299","journal-title":"Ann N Y Acad Sci"},{"key":"2009_CR9","first-page":"271","volume-title":"Physiological pharmaceutics: Barriers to drug absorption","author":"N Washington","year":"2001","unstructured":"Washington N, Washington C, Wilson CG (2001) Vaginal and intrauterine drug delivery. In: Washington N, Washington C, Wilson CG (eds) Physiological pharmaceutics: Barriers to drug absorption. Taylor and Francis, London, pp 271\u2013281"},{"key":"2009_CR10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/2136191","volume":"28","author":"L Potter","year":"1996","unstructured":"Potter L, Oakley D, de Leon-Wong E, Canamar R (1996) Measuring compliance among oral contraceptive users. Fam Plan Perspect 28:154\u2013158","journal-title":"Fam Plan Perspect"},{"key":"2009_CR11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/bmj.287.6401.1247","volume":"287","author":"LG Patel","year":"1984","unstructured":"Patel LG et al (1984) Propranolol concentrations in plasma after insertion into the vagina. Br Med J 287:1247\u20131248","journal-title":"Br Med J"},{"key":"2009_CR12","first-page":"693","volume":"72","author":"M Varmesh","year":"1988","unstructured":"Varmesh M et al (1988) Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women. Obstet Gynecol 72:693\u2013698","journal-title":"Obstet Gynecol"},{"key":"2009_CR13","first-page":"157","volume-title":"Clinical pharmacokinetics, concepts and applications","author":"M Rowland","year":"1995","unstructured":"Rowland M, Towzer TN (1995) Elimination. In: Balado D (ed) Clinical pharmacokinetics, concepts and applications, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, p 157","edition":"3"},{"key":"2009_CR14","doi-asserted-by":"crossref","unstructured":"Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD (1997 Jul) Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 90(1):88\u201392","DOI":"10.1016\/S0029-7844(97)00111-7"},{"key":"2009_CR15","unstructured":"Okada H (1991) Vaginal route of peptide and protein delivery. In: Lee,VHL (ed) Peptide and protein drug delivery. Marcel Dekker, pp 633\u2013666"},{"key":"2009_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-5122(88)90066-7","volume":"10","author":"K Carlstrom","year":"1988","unstructured":"Carlstrom K, Pschera H, Lunell NO (1988) Serum levels of oestrogens, progesterone, follicle-stimulating hormone and sexhormone- binding globulin during simultaneous vaginal administration of 17-h-oestradiol and progesterone in the pre- and post-menopause. Maturitas 10:307\u2013316","journal-title":"Maturitas"},{"key":"2009_CR17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000293657","volume":"27","author":"H Pschera","year":"1989","unstructured":"Pschera H, Hjerpe A, Carlstrom K (1989) Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17-h and progesterone in postmenopausal women. Gynecol Obstet Investig 27:204\u2013207","journal-title":"Gynecol Obstet Investig"},{"key":"2009_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45439-7","volume":"35","author":"B Villanueva","year":"1981","unstructured":"Villanueva B, Casper RF, Yen SSC (1981) Intravaginal administration of progesterone: enhanced absorption after oestrogen treatment. Fertil Steril 35:433\u2013437","journal-title":"Fertil Steril"},{"key":"2009_CR19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0169-409X(93)90017-X","volume":"11","author":"DF Katz","year":"1993","unstructured":"Katz DF, Dunmire EN (1993) Cervical mucus. Problems and opportunities for drug delivery via the vagina and cervix. Adv Drug Deliv Rev 11:385\u2013401","journal-title":"Adv Drug Deliv Rev"},{"key":"2009_CR20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1471-0528.1992.tb14433.x","volume":"99","author":"TA Johnson","year":"1992","unstructured":"Johnson TA, Greer IA, Kelly RW, Calder AA (1992) The effect of pH on release of PGOESTRADIOL from vaginal and endocervical preparations for induction of labour: an in-vitro study. Br J Obstet Gynaecol 99:877\u2013880","journal-title":"Br J Obstet Gynaecol"},{"key":"2009_CR21","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/jps.2600651105","volume":"65","author":"S Hwang","year":"1977","unstructured":"Hwang S, Wada EO, Yotsuanagi T, Suhardja I, Ho NFH, Flynn GL, Higuchi WI (1977) Systems approach to vaginal delivery of drugs: II. In situ vaginal absorption of unbranched aliphatic alcohols. J Pharm Sci 65:1574\u20131578","journal-title":"J Pharm Sci"},{"key":"2009_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0169-409X(93)90031-X","volume":"11","author":"L Brannon-Peppas","year":"1992","unstructured":"Brannon-Peppas L (1992) Novel vaginal drug release applications. Adv Drug Deliv Rev 11:169\u2013177","journal-title":"Adv Drug Deliv Rev"},{"key":"2009_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/096032719000900202","volume":"9","author":"JM Sanders","year":"1990","unstructured":"Sanders JM, Matthews HB (1990) Vaginal absorption of polyvinyl alcohol in Fischer 344 rats. Hum Exp Toxicol 9:71\u201377","journal-title":"Hum Exp Toxicol"},{"key":"2009_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/108729100317803","volume":"14","author":"PF Harrison","year":"2000","unstructured":"Harrison PF (2000) Microbicides: forging scientific and political alliances. AIDS Patient Care STDs 14:199\u2013205","journal-title":"AIDS Patient Care STDs"},{"key":"2009_CR25","unstructured":"Forbes A (2000) Beyond latex: will microbicides offer an alternative to condom? Body Positive, XIII"},{"key":"2009_CR26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0015-0282(97)00545-1","volume":"69","author":"E Cicinelli","year":"1998","unstructured":"Cicinelli E et al (1998) Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women. Fertil Steril 69:471\u2013473","journal-title":"Fertil Steril"},{"key":"2009_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-8545(21)00583-0","volume":"14","author":"MI Cedars","year":"1987","unstructured":"Cedars MI, Judd HL (1987) Non-oral routes of oestrogen administration. Obstet Gynecol Clin North Am 14:269\u2013298","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2009_CR28","first-page":"393","volume":"48","author":"M Guyot","year":"1993","unstructured":"Guyot M, Fawaz F (1993) Intravaginal pharmaceutical dosage forms: present and future choices. Part 1. Classic products. J Pharm Belg 48:393\u2013406","journal-title":"J Pharm Belg"},{"key":"2009_CR29","first-page":"85","volume":"19","author":"S Calis","year":"1994","unstructured":"Calis S et al (1994) Topical vaginal dosage forms, their formulations, applications and controls. Farm Bilimer Derg 19:85\u201395","journal-title":"Farm Bilimer Derg"},{"key":"2009_CR30","first-page":"202","volume":"70","author":"VE Johnson","year":"1962","unstructured":"Johnson VE, Masters WH (1962) Intravaginal contraceptive study: phase I. Anatomy. West J Surg Obstet Gynecol 70:202\u2013207","journal-title":"West J Surg Obstet Gynecol"},{"key":"2009_CR31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00007435-199803000-00012","volume":"25","author":"L DuBouchet","year":"1998","unstructured":"DuBouchet L, McGregor JA, Ismail M, McCormack WM (1998) A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of trichomonas vaginalis vaginitis. Sex Transm Dis 25:176\u2013179","journal-title":"Sex Transm Dis"},{"key":"2009_CR32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-3083.1996.d01-320.x","volume":"44","author":"L Wassen","year":"1996","unstructured":"Wassen L, Schon K, Holmgren L, Jerborn M, Lycke N (1996) Local intravaginal vaccination of the female genital tract. Scand J Immunol 44:408\u2013414","journal-title":"Scand J Immunol"},{"key":"2009_CR33","first-page":"115","volume":"47","author":"M Rabl","year":"2002","unstructured":"Rabl M, Joura EA, Yucel Y, Egarter CA (2002) A randomized trial of vaginal prostaglandin OESTRADIOL for induction of labor, insert vs. tablet. J Reprod Med 47:115\u2013119","journal-title":"J Reprod Med"},{"key":"2009_CR34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1600-0412.2003.00246.x","volume":"82","author":"A Shetty","year":"2003","unstructured":"Shetty A, Livingstone I, Acharya S, Rice P, Danielian P, Templeton A (2003) Oral misoprostol (100 Ag) versus vaginal misoprostol (25 Ag) in term labor induction: a randomized comparison. Acta Obstet Gynecol Scand 82:1103\u20131106","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"33","key":"2009_CR35","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1016\/j.biomaterials.2011.07.068","volume":"32","author":"NK Malavia","year":"2011","unstructured":"Malavia NK, Zurakowski D, Schroeder A, Princiotto AM, Laury AR, Barash HE, Sodroski J, Langer R, Madani N, Kohane DS (2011) Liposomes for HIV prophylaxis. Biomaterials 32(33):8663\u20138668, Epub 2011 Sep 8","journal-title":"Biomaterials"},{"issue":"32","key":"2009_CR36","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1016\/j.vaccine.2011.05.013","volume":"29","author":"JR Carmichael","year":"2011","unstructured":"Carmichael JR, Pal S, Tifrea D, de la Maza LM (2011) Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine. Vaccine 29(32):5276\u20135283, Epub 2011 May 24","journal-title":"Vaccine"},{"key":"2009_CR37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1254\/fpj.98.1_31","volume":"98","author":"A Yamashita","year":"1991","unstructured":"Yamashita A, Oshima S, Matsuo K, Ito K, Ito A, Mori Y (1991) Pharmacological studies of intravaginally applied dehydroepiandrosterone sulfate. Folia Pharmacol Jpn 98:31\u201339","journal-title":"Folia Pharmacol Jpn"},{"key":"2009_CR38","first-page":"121","volume":"21","author":"RA Vukovich","year":"1977","unstructured":"Vukovich RA, Heald A, Darragh A (1977) Vaginal absorption of two imidazole anti-fungal agents, econazole and miconazole. Clin Pharmacol Ther 21:121\u2013125","journal-title":"Clin Pharmacol Ther"},{"key":"2009_CR39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/endo-78-1-208","volume":"78","author":"PJ Dzuik","year":"1966","unstructured":"Dzuik PJ, Cook B (1966) Passage of steroids through silicone rubber. Endocrinology 78:208\u2013211","journal-title":"Endocrinology"},{"key":"2009_CR40","first-page":"245","volume-title":"Progestins and antiprogestins in clinical practice","author":"D Shoupe","year":"2000","unstructured":"Shoupe D, Mishell DR Jr (2000) Contraceptive vaginal rings. In: Sitruk-Ware R, Mishell DR (eds) Progestins and antiprogestins in clinical practice. Dekker, New York, pp 245\u2013257"},{"key":"2009_CR41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2001-18646","volume":"19","author":"B Harwood","year":"2001","unstructured":"Harwood B, Mishell DR (2001) Contraceptive vaginal rings. Semin Reprod Med 19:381\u2013390","journal-title":"Semin Reprod Med"},{"key":"2009_CR42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","volume":"41","author":"World Health Organization","year":"1990","unstructured":"World Health Organization (1990) Microdose intravaginal levonorgestrel contraception\u2014a multicentre clinical trial I: contraceptive efficacy and side effects. Contraception 41:105\u2013124","journal-title":"Contraception"},{"key":"2009_CR43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14656566.4.2.201","volume":"4","author":"G Dezarnaulds","year":"2003","unstructured":"Dezarnaulds G, Fraser IS (2003) Vaginal ring delivery of hormone replacement therapy: a review. Expert Opin Pharmacother 4:201\u2013212","journal-title":"Expert Opin Pharmacother"},{"key":"2009_CR44","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0002-9378(99)70042-6","volume":"180","author":"DE Tourgeman","year":"1999","unstructured":"Tourgeman DE, Gentzchein E, Stanczyk FZ, Paulson RJ (1999) Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol 180:1480\u20131483","journal-title":"Am J Obstet Gynecol"},{"key":"2009_CR45","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","volume":"180","author":"BC Eriksen","year":"1999","unstructured":"Eriksen BC (1999) A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 180:1072\u20131079","journal-title":"Am J Obstet Gynecol"},{"key":"2009_CR46","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/humrep\/13.7.1952","volume":"13","author":"M Igarashi","year":"1998","unstructured":"Igarashi M, Iizuka M, Abe Y, Ibuki Y (1998) Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis. Hum Reprod 13:1952\u20131956","journal-title":"Hum Reprod"},{"key":"2009_CR47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/10837459609029888","volume":"1","author":"CH Lee","year":"1996","unstructured":"Lee CH, Chien YW (1996) In vitro permeation study of a mucoadhesive drug delivery for controlled delivery of nonoxynol- 9. Pharm Dev Technol 1:135\u2013145","journal-title":"Pharm Dev Technol"},{"key":"2009_CR48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1081\/DDC-100105179","volume":"27","author":"GC Ceschel","year":"2001","unstructured":"Ceschel GC, Maffei P, Borgia SL, Ronchi C, Rossi S (2001) Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm 27:541\u2013547","journal-title":"Drug Dev Ind Pharm"},{"key":"2009_CR49","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3109\/03639049109048536","volume":"17","author":"A Joglekar","year":"1991","unstructured":"Joglekar A et al (1991) Preferences of women for use of intravaginal medications. Drug Dev Ind Pharm 17:2103\u20132113","journal-title":"Drug Dev Ind Pharm"},{"key":"2009_CR50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-199811000-00022","volume":"12","author":"C Coggins","year":"1998","unstructured":"Coggins C et al (1998) Women\u2019s preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS 12:1389\u20131391","journal-title":"AIDS"},{"key":"2009_CR51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0010-7824(98)00104-8","volume":"58","author":"E Hardy","year":"1998","unstructured":"Hardy E et al (1998) Women\u2019s preferences for vaginal antimicrobial contraceptives III. Choice of a formulation, applicator, and packaging. Contraception 58:245\u2013249","journal-title":"Contraception"},{"key":"2009_CR52","doi-asserted-by":"crossref","unstructured":"Jirschele K, Sand PK (2012) Oxybutynin: past, present, and future. Int Urogynecol J [Epub ahead of print]","DOI":"10.1007\/s00192-012-1915-8"},{"key":"2009_CR53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v17.i5.30","volume":"17","author":"AD Woolfson","year":"2000","unstructured":"Woolfson AD, Malcolm RK, Gallagher R (2000) Drug delivery by the intravaginal route. Crit Rev Ther Drug Carrier Syst 17:509\u2013555","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"2009_CR54","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0090-4295(02)02577-3","volume":"61","author":"RM Levin","year":"2003","unstructured":"Levin RM, Whitbeck C, Borow A, Burden O, Leggett RE (2003) Effectiveness of vaginally administered oxybutynin on rabbit bladder function. Urology 61:1273\u20131277","journal-title":"Urology"},{"key":"2009_CR55","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.ju.0000092557.02298.da","volume":"171","author":"EC Chou","year":"2004","unstructured":"Chou EC, Whitbeck C, Borow A et al (2004) Inhibition of hyperreflexia by vaginally administered oxybutynin: a novel rabbit model. J Urol 171:958\u2013962","journal-title":"J Urol"},{"key":"2009_CR56","first-page":"S138","volume":"22","author":"M Gittleman","year":"2011","unstructured":"Gittleman M, Reape KZ, Dasen S, Hait HI (2011) A phase 2 study evaluating the safety and efficacy of two doses of a monthly oxybutynin vaginal ring in women with symptoms of overactive bladder. Int Urogynecol J 22:S138\u2013S139","journal-title":"Int Urogynecol J"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-012-2009-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-012-2009-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T22:54:04Z","timestamp":1643842444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-012-2009-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2009"],"URL":"https:\/\/doi.org\/10.1007\/s00192-012-2009-3","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]}}}